<code id='6AA85714CC'></code><style id='6AA85714CC'></style>
    • <acronym id='6AA85714CC'></acronym>
      <center id='6AA85714CC'><center id='6AA85714CC'><tfoot id='6AA85714CC'></tfoot></center><abbr id='6AA85714CC'><dir id='6AA85714CC'><tfoot id='6AA85714CC'></tfoot><noframes id='6AA85714CC'>

    • <optgroup id='6AA85714CC'><strike id='6AA85714CC'><sup id='6AA85714CC'></sup></strike><code id='6AA85714CC'></code></optgroup>
        1. <b id='6AA85714CC'><label id='6AA85714CC'><select id='6AA85714CC'><dt id='6AA85714CC'><span id='6AA85714CC'></span></dt></select></label></b><u id='6AA85714CC'></u>
          <i id='6AA85714CC'><strike id='6AA85714CC'><tt id='6AA85714CC'><pre id='6AA85714CC'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:56937
          Humana sued the federal government Friday over a rule that claws back overpayments from it and other Medicare Advantage insurers. Adobe

          Humana sued the federal government Friday, arguing that this year’s new rule to claw back overpayments from it and other Medicare Advantage insurers violates federal law due to its “shifting justifications and erroneous legal reasoning.”

          “The [Centers for Medicare and Medicaid Services] did not even try to offer an empirical or actuarial justification for its new audit methodology, relying instead on purely legal rationales — none of which withstand scrutiny,” Humana said in the lawsuit.

          advertisement

          The health insurance industry has threatened a lawsuit over this old and contentious auditing process since last year. Humana executives specifically mentioned at this year’s J.P. Morgan Healthcare Conference that they would consider suing the government if the audit rule did not contain certain components they deemed were necessary.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Readout Newsletter: Cytokinetics and Novartis' starcrossed tale
          Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

          SipaviaAPWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletter

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Let's speed up science by embracing open access publishing

          APStockSixyearsago,HarvardscientistJayBradnerdiscoveredsomethingunusual.Hislaboratoryhadisolatedamol